Product Development Policy | Research & Development | SENJU Pharmaceutica
atter condition is rare in Japan and generally known as a rare disease, yet there are many patients suffering from it worldwide and it is known as the most common hereditary corneal diseasesup#5,6. Cu...
http://www.senju.co.jp/english/rd/policy/